Vitamin D receptor gene polymorphisms and risk of osteoarthritis: a meta-analysis

Exp Biol Med (Maywood). 2014 May;239(5):559-67. doi: 10.1177/1535370213514920. Epub 2014 Mar 6.

Abstract

The vitamin D receptor (VDR) gene polymorphisms have been reported to be involved in the development of many musculoskeletal disorders, including osteoarthritis (OA). However, results were inconsistent and there is no definite conclusion regarding the association between any VDR polymorphism and the risk of OA. In this study, we conducted a meta-analysis to determine whether BsmI, TaqI, and ApaI polymorphisms in the VDR gene are associated with OA susceptibility. Literature research was performed using PubMed and EMBASE databases. Studies illustrating the association between the three VDR polymorphisms and OA were included, and their qualities were assessed using Newcastle-Ottawa scale. Eight eligible studies, recruiting 1626 cases and 2024 controls were identified. Their methodological qualities were generally good, with scores ranging from 6 to 8 points. However, throughout all summary analyses, which were performed for multiple categories and on four contrasts (allele contrast, contrast of homozygotes, recessive and dominant models), none of the VDR BsmI, TaqI, and ApaI gene polymorphisms were found to be significantly associated with the risk of OA. On the other hand, there was no significant publication bias. Results from this meta-analysis suggested that the VDR BsmI, TaqI, and ApaI gene polymorphisms might not be important predictors of OA. More studies further investigating these associations, especially taking into account of gene-gene, gene-environment interactions, and other confounding factors are warranted.

Keywords: Vitamin D receptor; meta-analysis; osteoarthritis; polymorphism.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genetic Predisposition to Disease*
  • Humans
  • Osteoarthritis / epidemiology*
  • Osteoarthritis / genetics*
  • Polymorphism, Genetic*
  • Receptors, Calcitriol / genetics*
  • Risk Assessment

Substances

  • Receptors, Calcitriol